These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12429071)

  • 21. FTO T/A and peroxisome proliferator-activated receptor-γ Pro12Ala polymorphisms but not ApoA1 -75 are associated with better response to lifestyle intervention in Brazilians at high cardiometabolic risk.
    Curti ML; Rogero MM; Baltar VT; Barros CR; Siqueira-Catania A; Ferreira SR
    Metab Syndr Relat Disord; 2013 Jun; 11(3):169-76. PubMed ID: 23438152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes.
    Memisoglu A; Hu FB; Hankinson SE; Liu S; Meigs JB; Altshuler DM; Hunter DJ; Manson JE
    Diabetes Care; 2003 Oct; 26(10):2915-7. PubMed ID: 14514601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.
    Iwata E; Yamamoto I; Motomura T; Tsubakimori S; Nohnen S; Ohmoto M; Igarashi T; Azuma J
    Diabetes Res Clin Pract; 2003 Oct; 62(1):55-9. PubMed ID: 14581158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.
    Ek J; Andersen G; Urhammer SA; Hansen L; Carstensen B; Borch-Johnsen K; Drivsholm T; Berglund L; Hansen T; Lithell H; Pedersen O
    Diabetologia; 2001 Sep; 44(9):1170-6. PubMed ID: 11596673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the Ala12 variant of the PPARG gene an "unthrifty allele"?
    Ruiz-Narváez E
    J Med Genet; 2005 Jul; 42(7):547-50. PubMed ID: 15994875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of a new PPARgamma2 promoter polymorphism and haplotype analysis in a French population.
    Meirhaeghe A; Tanck MW; Fajas L; Janot C; Helbecque N; Cottel D; Auwerx J; Amouyel P; Dallongeville J
    Mol Genet Metab; 2005 Jun; 85(2):140-8. PubMed ID: 15896659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.
    Johansson LE; Danielsson P; Norgren S; Marcus C; Ridderstråle M
    Int J Pediatr Obes; 2009; 4(2):119-25. PubMed ID: 18645733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men.
    Mori Y; Kim-Motoyama H; Katakura T; Yasuda K; Kadowaki H; Beamer BA; Shuldiner AR; Akanuma Y; Yazaki Y; Kadowaki T
    Biochem Biophys Res Commun; 1998 Oct; 251(1):195-8. PubMed ID: 9790929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.
    Memisoglu A; Hu FB; Hankinson SE; Manson JE; De Vivo I; Willett WC; Hunter DJ
    Hum Mol Genet; 2003 Nov; 12(22):2923-9. PubMed ID: 14506127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
    Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
    Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass.
    Memisoglu A; Hankinson SE; Manson JE; Colditz GA; Hunter DJ
    Pharmacogenetics; 2002 Nov; 12(8):597-603. PubMed ID: 12439219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients.
    Vaccaro O; Lapice E; Monticelli A; Giacchetti M; Castaldo I; Galasso R; Pinelli M; Donnarumma G; Rivellese AA; Cocozza S; Riccardi G
    Diabetes Care; 2007 May; 30(5):1156-61. PubMed ID: 17259473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.
    Black MH; Wu J; Takayanagi M; Wang N; Taylor KD; Haritunians T; Trigo E; Lawrence JM; Watanabe RM; Buchanan TA; Xiang AH
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1187-95. PubMed ID: 25584717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
    Wang C; Zhai F; Chi Y; Wang G
    Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples.
    Zeggini E; Parkinson JR; Halford S; Owen KR; Walker M; Hitman GA; Levy JC; Sampson MJ; Frayling TM; Hattersley AT; McCarthy MI
    Diabet Med; 2005 Dec; 22(12):1696-700. PubMed ID: 16401314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.